Christopher Martin - 11 Dec 2025 Form 3 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Christopher Martin
Issuer symbol
ORKA
Transactions as of
11 Dec 2025
Transactions value $
$0
Form type
3
Filing time
11 Dec 2025, 16:32:48 UTC
Previous filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Martin Christopher Nathan Director C/O ORUKA THERAPEUTICS, INC., 855 OAK GROVE AVE., SUITE 100, MENLO PARK /s/ Paul Quinlan, as attorney-in-fact for Christopher Martin 11 Dec 2025 0002097992

No securities are beneficially owned.